Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ISMP Study Shows Pfizer Failed to Report Chantix Side Effects to FDA
Seeking Alpha
Thursday, May 19, 2011 - 1:51pm
tags:
ISMP, Pfizer, FDA, Chantix, smoking cessation
New Study Casts Doubt on Effectiveness of Abbott's TriCor/TriLipix
Seeking Alpha
Thursday, May 19, 2011 - 1:50pm
tags:
Abbott Laboratories, TriCor, TriLipix
Why Johnson & Johnson's Earnings Are Outstanding
Motley Fool
Thursday, May 19, 2011 - 1:47pm
tags:
earnings, JNJ
Where Have All The FDA Panelists Gone?
Pharmalot
Thursday, May 19, 2011 - 9:51am
tags:
FDA, advisory panels
Teva Positioned to Acquire Spectrum Pharmaceuticals?
Seeking Alpha
Thursday, May 19, 2011 - 9:49am
tags:
Teva Pharmaceuticals, M&A, Spectrum Pharmaceuticals
Experimental Pfizer Drug Slows Kidney Cancer in Large Trial
Bloomberg
Thursday, May 19, 2011 - 9:48am
tags:
Pfizer, kidney cancer, Axitinib
J&J Failed to Warn Parents About Motrin Risks, Lawyer Argues
Bloomberg
Thursday, May 19, 2011 - 9:46am
tags:
Motrin, JNJ
Japan's Takeda buying Nycomed for $13.6 billion
Yahoo/AP
Thursday, May 19, 2011 - 9:45am
tags:
Takeda, Japan, Nycomed, M&A, emerging markets
Glaxo’s Avandia Sales to Stop in U.S. Retail Pharmacies
Bloomberg
Thursday, May 19, 2011 - 9:43am
tags:
Avandia, GSK, diabetes
Top 2 Pharmaceutical Stocks Set to Soar
Seeking Alpha
Wednesday, May 18, 2011 - 6:39pm
tags:
Teva Pharmaceuticals, Vanda, generics, Fanapt, schizophrenia
AstraZeneca’s Olaparib Prolongs Remission in Ovarian Cancer
Bloomberg
Wednesday, May 18, 2011 - 6:37pm
tags:
AstraZeneca, ovarian cancer, olaparib
Celldex Therapeutics shares fall after company announces offering price of $3.15 per share
Yahoo/AP
Wednesday, May 18, 2011 - 6:35pm
tags:
Celldex, Pfizer, stock offering
Avandia — When A Drug Is On The Market, But Not Really
Forbes
Wednesday, May 18, 2011 - 6:34pm
tags:
diabetes, Avandia, GSK
Aeterna Zentaris posts better sales, but greater costs lead to wider 1st-quarter loss
Yahoo/AP
Wednesday, May 18, 2011 - 6:34pm
tags:
earnings, Aeterna Zentaris
11 Potential Biotech Buy Out Targets
Seeking Alpha
Wednesday, May 18, 2011 - 11:50am
tags:
M&A, Alexion, Celgene, Biogen Idec, Celldex, Geron, Illumina, Micromet, Mylan, Vical, Oncothyreon, Pharmasset
Roche cancer programs angle for a starring role at ASCO
Fierce Biotech
Wednesday, May 18, 2011 - 11:46am
tags:
Roche, ASCO, skin cancer, Plexxikon
ISTA Sues FDA Over Generic XIBROM Approval, Says ANDA Approval Should Disappear in the Blink of An Eye
FDA Law Blog
Wednesday, May 18, 2011 - 11:44am
tags:
Ista, generics, FDA, Xibrom, Coastal Pharmaceuticals
Cytrx: Another Stride Ensuring Continued Shareholder Value
Seeking Alpha
Wednesday, May 18, 2011 - 11:43am
tags:
CytRx, Orphazyme
Nikkei says Nycomed buyout imminent; Takeda says no
Fierce Pharma
Wednesday, May 18, 2011 - 11:41am
tags:
M&A, Takeda, Nycomed
Pfizer Blames Teva, Ivax for ’Billions’ in Neurontin Losses
Bloomberg
Wednesday, May 18, 2011 - 11:36am
tags:
Ivax Diagnostics, Teva Pharmaceuticals, Neurontin, Pfizer, generics, epilepsy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.